Featured Research

from universities, journals, and other organizations

New protocol reduces children's radiation exposure during cardiac procedures

Date:
November 15, 2010
Source:
American Heart Association
Summary:
Radiation exposure during cardiac procedures to diagnose and treat pediatric heart rhythm disturbances is not insignificant. Using a new safety protocol of continuous real-time radiation monitoring, physician awareness, and adjusting radiation dosing reduces children's radiation exposure as they undergo electrophysiology procedures. Unrelated research on radiation found women are more likely to develop cancer from ionizing radiation used in cardiac treatment and that medical imaging staff may need better protection from it.

A protocol that uses continuous real-time radiation monitoring, low-dose imaging programs and requires physician awareness of radiation dose, significantly reduced radiation exposure during electrophysiology procedures and catheter ablations to diagnose and treat heart arrhythmias in children, according to research presented at the American Heart Association's Scientific Sessions 2010.

Invasive cardiac electrophysiology is used to diagnose and treat abnormal heart rhythms, or arrhythmias, which can range from the benign to the life-threatening.

In the study, researchers looked at boys and girls at an average age of 14.5 years who underwent electrophysiology procedures to diagnose and treat arrhythmias. In the procedures, doctors use fluoroscopy, which is a continuous X-ray, to visually guide catheters in the heart which are inserted through blood vessels in the groin or neck that lead to the heart.

The downside of this imaging is that it exposes patients to a continuous flow of radiation, said Akash R. Patel, M.D., lead author of the study and an electrophysiology fellow in the Division of Cardiology at The Children's Hospital of Philadelphia in Pa. "Radiation exposure in pediatric electrophysiology procedures is not insignificant. We compared the radiation exposure of 70 children who had undergone the procedures before we began the protocol to that of 61 children who had the procedures after we instituted the protocol."

The new protocol uses a low dose fluoroscopy setting and continuous real-time monitoring of radiation exposure. When the radiation dose registers at certain levels, the physician is notified so that the he or she can adjust the fluoroscopy cameras to minimize exposure.

The researchers found significantly reduced radiation exposure among children whose procedures were performed using the new protocol, including:

  • 22 percent reduction in the time that the X-ray machine was on
  • 52 percent reduction in the dose of X-ray entering the skin, which helps to prevent skin injury
  • 51 percent reduction in median effective dose, which correlates with the lifetime increased risk of cancer from radiation exposure.

"While we did not measure what these lower doses mean in the long run, we presume, for example, that reducing the effective dose will decrease the child's lifetime increased cancer risk from radiation exposure," Patel said.

"The public should be aware of radiation exposure from electrophysiology procedures, and physicians and hospitals should be vigilant in implementing protocols aimed at reducing radiation exposure from these procedures. This is especially important in children to minimize their risk of radiation-induced cancer because they should live for many decades after their procedures."

Co-authors are: Jamie Ganley, B.S.; Xiaowei Zhu, M.S., Jonathan J. Rome, M.D.; Maully Shah, M.B.B.S.; and Andrew C. Glatz, M.D. Author disclosures are on the abstract.

The Children's Hospital of Philadelphia funded the study.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "New protocol reduces children's radiation exposure during cardiac procedures." ScienceDaily. ScienceDaily, 15 November 2010. <www.sciencedaily.com/releases/2010/11/101114161832.htm>.
American Heart Association. (2010, November 15). New protocol reduces children's radiation exposure during cardiac procedures. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/11/101114161832.htm
American Heart Association. "New protocol reduces children's radiation exposure during cardiac procedures." ScienceDaily. www.sciencedaily.com/releases/2010/11/101114161832.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins